News
|
Contact us
|
Careers
|
Media centre
Home
Womens services
Mens services
Young peoples services
Our centres
Fees
Book now
Resources
Health professionals
02:35, 22 March 2010
Abortion
Abortion clinics
Abortion costs
Abortion information
Vasectomy
Vasectomy clinics
Vasectomy costs
Vasectomy information
Women's health screening
Women's health screening clinics
Women's health screening costs
Women's health screening information
Men's health screening
Men's health screening clinics
Men's health screening costs
Men's health screening information
Company health screening
Chlamydia testing
Women's chlamydia testing
Men's chlamydia testing
Cervical smear testing
Fees for services
Abortion
Abortion clinics
Abortion costs
Abortion information
Vasectomy
Vasectomy clinics
Vasectomy costs
Vasectomy information
Women's health screening
Women's health screening clinics
Women's health screening costs
Women's health screening information
Men's health screening
Men's health screening clinics
Men's health screening costs
Men's health screening information
Company health screening
Chlamydia testing
Women's chlamydia testing
Men's chlamydia testing
Fees for services
Media centre
»
Press releases
Research shows new emergency contraceptive pill is effective in preventing pregnancies
New research published today (Friday) in The Lancet (online first: www.thelancet.com) shows that the new emergency contraceptive pill ellaOne® (ulipristal acetate) is effective in preventing pregnancies. Leading sexual health charity Marie Stopes International makes the following statement:
“We welcome the research which shows that the new emergency contraceptive pill, ellaOne (ulipristal acetate), is effective in preventing pregnancy.
"No method of contraception is 100% effective, and emergency contraception therefore plays a vital role in preventing the emotional, social and financial consequences of an unintended pregnancy. Emergency contraception should not replace a regular contraceptive method, but is a valuable back-up in emergency situations when a regular contraceptive method has not been used consistently or has failed – if a woman has forgotten to take her contraceptive pill, or when a condom breaks for example.
“As the research reveals, both ellaOne and Levonelle (levonorgestrel) are effective in preventing pregnancy and both have been approved by medical authorities as safe and effective methods of emergency contraception. However, the advantages of ellaOne is that it can be taken for up to five days after unprotected sex, compared to Levonelle which is taken within three days of unprotected sex. The five day window may be beneficial to women who can not access emergency contraception promptly, for example women who have unprotected sex whilst on holiday or over the weekend when doctors surgeries and pharmacies might be closed.
“We are delighted that ellaOne is now available to women across the UK, providing women and healthcare providers with an alternative choice for emergency contraception. However ellaOne is only available with a prescription, so women wishing to use it should visit their doctor as soon as possible for advice.
"It is also important to remember that emergency contraception does not protect against sexually transmitted infections (STIs). We would encourage women who have had unprotected sex to visit their GP or local family planning centre for an STI test.”
- Ends -
All quotes are attributable to Emily James, Marie Stopes International.
For further information please contact the Marie Stopes International press office:
Emily James, Deputy Manager UK Press and Public Affairs: +44 (0) 207 034 2307 / emily.james@mariestopes.org.uk
Tony Kerridge, Senior Communications Manager: +44 (0) 207 034 2365 / tony.kerridge@mariestopes.org.uk
Categories: Emergency contraception
29/01/2010
« Back to list
Press releases
Press Archive
Marie Stopes International in the news
Resources for journalists
BACK TO TOP »
About us
|
For health professionals
|
Campaigning
|
Sitemap
|
Support our work overseas
|
Abortion
|
Vasectomy
Privacy Statement